An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span ...

Vertex Pharmaceuticals’ non-opioid pain medication is up for FDA approval this week. Other drugmakers have found safer ...

Eli Lilly (LLY) closed the latest trading day at $804.99, indicating a -0.39% change from the previous session's end. The stock trailed the S&P 500, which registered a daily gain of 0.92%. At the same ...

Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

2025 Healthcare & Pharmaceuticalscategory Novo Nordisk to cap insulin prices in Minnesota settlement; joins Lilly, Sanofi January 27, 2025 ...

The use of animals in pharmaceutical testing is often a necessity for life sciences companies – this can attract the attention of animal rights activists, who may target company facilities or ...